Skip to main content
Cellular and Molecular Life Sciences: CMLS logoLink to Cellular and Molecular Life Sciences: CMLS
. 2004 Apr;61(9):1075–1081. doi: 10.1007/s00018-004-3477-5

Ubiquitin-proteasome pathway as a primary defender against TRAIL-mediated cell death

S Kim 1, K Choi 1, D Kwon 2, E N Benveniste 2, C Choi 1,2,
PMCID: PMC11138569  PMID: 15112054

Abstract

Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptotic cell death as well as expression of proinflammatory genes such as CXCL8 in malignant human astrocytoma cells. However, the molecular mechanisms that determine the fate of cells are not yet understood. The ubiquitin (Ub)-proteasome pathway regulates a wide range of cellular functions through degradation of various regulatory proteins; given this, we hypothesized that this pathway may play a central role in TRAIL-mediated signaling. We demonstrate here that inhibition of the Ub-proteasome pathway enhanced TRAIL-mediated cell death of human astrocytoma CRT-MG cells within hours by blocking degradation of active caspase-8 and -3. Proteasome inhibitors suppressed TRAIL-mediated activation of NF-κB; however, inhibition of the NF-κB pathway alone was not sufficient to enhance TRAIL-mediated cell death. Collectively, these results suggest that the Ub-proteasome pathway may play an important role as an antiapoptotic surveillance system by eliminating activated caspases as well as mediating NF-κB-dependent signals.

Keywords: Proteasome, caspase, apoptosis, TRAIL, astrocytoma;ubiquitin

Footnotes

Received 30 December 2003; received after revision 9 February 2004; accepted 13 February 2004


Articles from Cellular and Molecular Life Sciences: CMLS are provided here courtesy of Springer

RESOURCES